Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
I
389470
vs
K
KOSPI 200
Over the past 12 months, Inventage Lab Inc has underperformed KOSPI 200, delivering a return of -26% compared to KOSPI 200's +125% growth.
Stocks Performance
389470 vs KOSPI 200
Performance Gap
389470 vs KOSPI 200
Performance By Year
389470 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Inventage Lab Inc
Glance View
Inventage Lab, Inc. engages in researches and develops biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2022-11-22. The firm owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The firm is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. The company is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.